The role of interleukin-2 in the treatment of cancer patients

Wagstaff, J.

Recombinant human interleukin-2 became available for clinical use in the mid 1980s. Recent years have seen an enormous amount of clinical research with this cytokine and interleukin-2 has now been registered for use in a number of European countries for the treatment of metastatic renal cell carcinoma. This book is designed to provide the clinical oncologist wishing to use interleukin-2 with a basic background concerning the biology of the agent, a discussion concerning practical aspects, of its clinical use including management of toxicity and an overview of the clinical results together with a description of how this internesting cytokine might be developed in the future.

Details

Published by: Springer

Publication Date: 2012-10-29

Format: Paperback

ISBN-13: 9789401047692

DOI: 10.1007/978-94-011-1753-1

Dimensions: 240.0cm x160.0cm

Pages: 191.0